ADICON

ADICON operates one of China's largest independent clinical laboratory networks with over thirty-five self-operated labs. It offers more than four thousand medical diagnostic tests—including routine, esoteric, molecular biology, immunologic, chemistry, and pathology tests—serving hospitals, health check centers, consumers, pharmaceutical companies and CROs. The company has industry-leading ISO15189 accreditation for its labs. In recent years it has invested heavily in digital transformation including LIMS upgrades and AI-powered pathology/image analysis to improve efficiency and accuracy. Its core business segments are growing steadily post-COVID adjustment year; base testing grew by over eight percent in the most recent year while esoteric testing grew by more than eighteen percent. No clinical trial results as it does not develop therapeutics.